In Special Issue 9 of 2019 S. Tiefenbacher and R.C. Gosselin (Colorado Coagulation, Laboratory Corporation of America Holdings, Englewood, CO USA
and Thrombosis & Hemostasis Center, University of California, Davis Health System, Sacramento, CA USA) described the laboratory measurement of extended half-life FVIII products.
